![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 49, 38921-38928, December 8, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
¶
From the Insulin-like growth factor (IGF-1) is a potent
mitogen for vascular smooth muscle cells. Both IGF-1 and its receptor
have been shown to be highly expressed in atherosclerotic lesions. Here
we investigated whether part of the vasculoprotective properties of
E2 may be mediated by its negative regulation of the IGF-1 system. HeLa cells, which do not contain endogenous estrogen receptors (ER), were transiently transfected with IGF-1R promoter constructs with
or without a plasmid encoding human ER
Division of Cardiology, University Hospital of Geneva,
1211 Geneva 14, Switzerland and the § Department of Cell Biology,
University of Geneva, 1211 Geneva 4, Switzerland
or ER
and treated with 100 nM 17
-estradiol (E2) for 24 h.
E2 treatment decreased basal luciferase activity by 51%,
and this effect was dependent on co-expression of ER
, whereas no
repression was observed with ER
. A mutation within the DNA binding
domain of the ER
abolished the repressor function of the ER
receptor. Similarly, E2 decreased IGF-1R transcription by
21% in rat aortic smooth muscle cells (RASMC), which express
endogenous ER. This effect was specific for E2, because it
was inhibited by an antiestrogen and because progesterone did not have
any effect on IGF-1R expression in HeLa or RASMC transfected with
progesterone receptor. Accordingly, E2 decreased IGF-1R and
IGF-1 mRNA in RASMC by 47% and 33%. Western blot analysis and
radioligand binding studies showed that E2 also dose-dependently decreased IGF-1R protein expression in
RASMC by 40% and 30%, respectively, and that IGF-1 protein was
reduced by 43%. Repression of IGF-1R promoter activity by a
combination of ER
and E2 did not appear to be mediated
via direct binding of ER to the IGF-1R promoter but rather by
inhibition of SP1 binding to the IGF-1R promoter. Thus, E2
down-regulates IGF-1R and IGF-1 expression in vascular smooth muscle
cells. This may have important implications for the understanding of
the beneficial effects of estrogen in the cardiovascular system.
This article has been cited by other articles:
![]() |
J. Kawagoe, M. Ohmichi, S. Tsutsumi, T. Ohta, K. Takahashi, and H. Kurachi Mechanism of the Divergent Effects of Estrogen on the Cell Proliferation of Human Umbilical Endothelial Versus Aortic Smooth Muscle Cells Endocrinology, December 1, 2007; 148(12): 6092 - 6099. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bonnefont, L. Daulhac, M. Etienne, E. Chapuy, C. Mallet, L. Ouchchane, C. Deval, J.-P. Courade, M. Ferrara, A. Eschalier, et al. Acetaminophen Recruits Spinal p42/p44 MAPKs and GH/IGF-1 Receptors to Produce Analgesia via the Serotonergic System Mol. Pharmacol., February 1, 2007; 71(2): 407 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Maor, D. Mayer, R. I Yarden, A. V Lee, R. Sarfstein, H. Werner, and M. Z Papa Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1 J. Endocrinol., December 1, 2006; 191(3): 605 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Elliot, M. Karl, M. Berho, X. Xia, S. Pereria-Simon, D. Espinosa-Heidmann, and G. E. Striker Smoking Induces Glomerulosclerosis in Aging Estrogen-Deficient Mice through Cross-Talk between TGF-beta1 and IGF-I Signaling Pathways J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3315 - 3324. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matuszewska, D. Kuczynska-Wisnik, E. Laskowska, and K. Liberek The Small Heat Shock Protein IbpA of Escherichia coli Cooperates with IbpB in Stabilization of Thermally Aggregated Proteins in a Disaggregation Competent State J. Biol. Chem., April 1, 2005; 280(13): 12292 - 12298. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Karl, M. Potier, I. H. Schulman, A. Rivera, H. Werner, A. Fornoni, and S. J. Elliot Autocrine Activation of the Local Insulin-Like Growth Factor I System Is Up-Regulated by Estrogen Receptor (ER)-Independent Estrogen Actions and Accounts for Decreased ER Expression in Type 2 Diabetic Mesangial Cells Endocrinology, February 1, 2005; 146(2): 889 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Delafontaine, Y.-H. Song, and Y. Li Expression, Regulation, and Function of IGF-1, IGF-1R, and IGF-1 Binding Proteins in Blood Vessels Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 435 - 444. [Abstract] [Full Text] |
||||
![]() |
C. K. Cheng, B. K. C. Chow, and P. C. K. Leung An Activator Protein 1-Like Motif Mediates 17{beta}-Estradiol Repression of Gonadotropin-Releasing Hormone Receptor Promoter via an Estrogen Receptor {alpha}-Dependent Mechanism in Ovarian and Breast Cancer Cells Mol. Endocrinol., December 1, 2003; 17(12): 2613 - 2629. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zaina, L. Pettersson, A. B. Thomsen, C.-M. Chai, Z. Qi, J. Thyberg, and J. Nilsson Shortened Life Span, Bradycardia, and Hypotension in Mice with Targeted Expression of an Igf2 Transgene in Smooth Muscle Cells Endocrinology, June 1, 2003; 144(6): 2695 - 2703. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kressler, S. N. Schreiber, D. Knutti, and A. Kralli The PGC-1-related Protein PERC Is a Selective Coactivator of Estrogen Receptor alpha J. Biol. Chem., April 12, 2002; 277(16): 13918 - 13925. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Sharma, M. V. Gurjar, and R. C. Bhalla Genome and Hormones: Gender Differences in Physiology: Selected Contribution: Estrogen receptor-alpha gene transfer inhibits proliferation and NF-kappa B activation in VSM cells from female rats J Appl Physiol, November 1, 2001; 91(5): 2400 - 2406. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |